Searched for
BEST ASSET CLASS
NRI Talk | Rupee depreciation shouldn't deter NRIs; India still offers attractive dollar returns: Feroze AzeezNRIs are questioning India's investment appeal due to recent flat returns and rupee depreciation. However, experts emphasize India's strong...
Entrepreneurship and innovation: Scaling India's strategic technology ecosystemIndia's pursuit of technological self-reliance is gathering pace as sovereign capabilities in defence, space, semiconductors, and secure co...
NRI Talk| For a Rs 50 crore NRI portfolio, structure matters as much as stock selection: Tarun BiraniNRIs view India with cautious optimism, recognizing its long-term growth potential despite recent market flatness and rupee depreciation. D...
Global equity returns: Japan top performer in 2026 so far with 36.8% return; know where India ranksWelcome to TrendMap, your visual guide to investment performance. This edition tracks 10 years of global equity returns. Currency fluctuati...
Over 10% of luxury home sales now come from NRIs across key global markets: Whiteland's Sudeep BhattIndia's luxury housing market is experiencing a structural transformation, attracting significant global capital, particularly from Non-Res...
Investing over Rs 43,000 monthly through SIPs? Here’s what an expert recommends for 20-year investment journeyA financial expert reviews a Rs 43,500 monthly SIP portfolio built for a 20-year horizon and suggests minimal changes. The key recommendati...
Adding gold to portfolio can boost returns without significantly increasing risk: WhiteOak studyA WhiteOak Capital study highlights the benefits of a multi-asset strategy, showing that combining equity, debt and gold can improve risk-a...
One balance, many markets: Binance and the making of a finance ‘super app’Binance is revolutionizing investing by consolidating crypto, stocks, and commodities into a single platform, mirroring Asia's 'super app' ...
Should you stop your SIP because the market is not doing well? History suggests otherwiseMarket downturns often tempt investors to pause their SIPs, but historical data suggests staying invested may be the better strategy. A Whi...
Bitcoin crashes 50%: Should you buy the dip or stay away from crypto?Investors must weigh extreme volatility, uncertain cycles and India’s harsh tax rules before adding exposure.
ITR filing AY 2026-27: 8 costly mistakes taxpayers should avoid this tax return filing seasonThe I-T Department’s growing scrutiny, using AI and data analytics tools, leaves little room for omissions and errors, making accurate tax ...
'Sharks' in Bay of Bengal: Pakistan tries to reopen a dormant frontPakistan's new submarines are expanding its naval reach. These vessels can stay submerged longer, allowing operations far from home. Pakist...
How Life Cycle Funds aim to simplify long-term wealth creationIndian mutual fund houses are launching Life Cycle Funds, a new goal-based investment product. These funds automatically adjust asset alloc...
PMS vs mutual funds: 5 reasons to invest, and 5 red flags to watchPortfolio Management Services (PMS) offer structural advantages over mutual funds, allowing for concentrated portfolios, significant cash h...
Think index funds are foolproof? These 7 myths can lead to costly mistakesPassive investing has become mainstream in India, but several myths persist. Investors should not judge passive funds solely by low costs, ...
Anthropic block marks US reversal, warning to Silicon ValleyAmerica has taken a significant step by blocking foreign access to Anthropic's top AI models. This move follows concerns about bypassing se...
US ban on Anthropic's Fable 5 & Mythos 5 to put Indian IT services firms at competitive disadvantageUS restrictions on foreign access to Anthropic's advanced AI models, Mythos and Fable 5, are creating a significant competitive disadvantag...
Prime Litmus Investment Management launches real estate opportunities fund, a Category II AIFPrime Securities has launched the Prime Litmus Real Estate Opportunities Fund, a Category II AIF targeting Rs 750 crore with a Rs 250 crore...
$10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...
Asset allocation in 2026: Gold and silver outperform as equities struggle amid market volatilityWelcome to TrendMap, your quick, visual guide to the performance of different investment segments. In this edition, we present a 10-year pe...